"As long as we open up technology licensing, conservatively estimated, we should be able to achieve more than 200 million US dollars in licensing revenue!"
"Hiss~" Jiang Wenmin took another sharp intake of breath.
He knew technology was valuable, but he hadn't realized that this newly developed technology was worth so much.
Just licensing fees alone could net 200 million a year, and we're talking US dollars!?
That's already more than the profits Changqing Biological had made over the past decade combined...
All one could say was that Jiang Wenmin's limited vision restricted his imagination.
Some major medical technologies command astronomical licensing fees every year!
Especially in hot fields like "Alzheimer's disease," which have a vast number of patients and tremendous market potential.
"I plan to reserve the region south of the Yangtze River as Changqing Biological's own turf, where we will develop our own related downstream industries.
